Search research articles
Contact Us
Filters
Showing results (1071-1080 of 1,152) with videos related to
Page
of 116
Sort By:
Nature Medicine
|
December 12, 2017
A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway
Lorenz H Lehmann, Zegeye H Jebessa, Michael M Kreusser, et al.
Neurology
|
October 11, 2023
Relevance of Minor Neuropsychological Deficits in Patients With Subjective Cognitive Decline
Melina Stark, Steffen Wolfsgruber, Luca Kleineidam, et al.
Nature Communications
|
April 17, 2026
Dysfunction of the episodic memory network in the Alzheimer's disease cascade
René Lattmann, Niklas Vockert, Jose Bernal, et al.
Alzheimer'S Research & Therapy
|
November 24, 2021
Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer's disease
Martin Dyrba, Moritz Hanzig, Slawek Altenstein, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 3, 2025
Recessive genetic contribution to congenital heart disease in 5,424 probands
Weilai Dong, Sheng Chih Jin, Michael C Sierant, et al.
Brain Communications
|
February 10, 2025
CSF biomarkers are differentially linked to brain areas high and low in noradrenaline, dopamine and serotonin across the Alzheimer's disease spectrum
Lena Haag, Elisa Lancini, Renat Yakupov, et al.
Brain : a Journal of Neurology
|
October 26, 2022
Cholinergic white matter pathways along the Alzheimer's disease continuum
Milan Nemy, Martin Dyrba, Frederic Brosseron, et al.
Nature Chemical Biology
|
May 14, 2025
Small-molecule dissolution of stress granules by redox modulation benefits ALS models
Hiroyuki Uechi, Sindhuja Sridharan, Jik Nijssen, et al.
Molecular Psychiatry
|
April 17, 2025
Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s disease
David Mengel, Ester Soter, Julia Maren Ott, et al.
Communications Medicine
|
December 10, 2024
Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjects
Lara Blömeke, Fabian Rehn, Marlene Pils, et al.
Page
of 116
Search research articles
Search
Showing results (1071-1080 of 1,152) with videos related to
Sort By:
Page
of 116
Nature Medicine
|
December 12, 2017
A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway
Lorenz H Lehmann, Zegeye H Jebessa, Michael M Kreusser, et al.
Neurology
|
October 11, 2023
Relevance of Minor Neuropsychological Deficits in Patients With Subjective Cognitive Decline
Melina Stark, Steffen Wolfsgruber, Luca Kleineidam, et al.
Nature Communications
|
April 17, 2026
Dysfunction of the episodic memory network in the Alzheimer's disease cascade
René Lattmann, Niklas Vockert, Jose Bernal, et al.
Alzheimer'S Research & Therapy
|
November 24, 2021
Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer's disease
Martin Dyrba, Moritz Hanzig, Slawek Altenstein, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 3, 2025
Recessive genetic contribution to congenital heart disease in 5,424 probands
Weilai Dong, Sheng Chih Jin, Michael C Sierant, et al.
Brain Communications
|
February 10, 2025
CSF biomarkers are differentially linked to brain areas high and low in noradrenaline, dopamine and serotonin across the Alzheimer's disease spectrum
Lena Haag, Elisa Lancini, Renat Yakupov, et al.
Brain : a Journal of Neurology
|
October 26, 2022
Cholinergic white matter pathways along the Alzheimer's disease continuum
Milan Nemy, Martin Dyrba, Frederic Brosseron, et al.
Nature Chemical Biology
|
May 14, 2025
Small-molecule dissolution of stress granules by redox modulation benefits ALS models
Hiroyuki Uechi, Sindhuja Sridharan, Jik Nijssen, et al.
Molecular Psychiatry
|
April 17, 2025
Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s disease
David Mengel, Ester Soter, Julia Maren Ott, et al.
Communications Medicine
|
December 10, 2024
Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjects
Lara Blömeke, Fabian Rehn, Marlene Pils, et al.
Page
of 116